Skip to main content
. 2020 Dec 7;26(45):7153–7172. doi: 10.3748/wjg.v26.i45.7153

Table 1.

Demographics and clinical characteristics of patients with diarrhea-predominant irritable bowel syndrome and healthy controls

Features
IBS-D patients
Controls
P value
n 55 28 NA
Age in yr 35.1 ± 9.8 34.4 ± 10.6 0.754
Gender, male: Female 41: 14 5: 2 0.761
Body mass index in kg/m2 23.3 ± 3.4 22.6 ± 3.1 0.335
Duration of disease in yr 3.0 (1.5, 7.0) NA NA
Defecation frequency 3.5 (2.5, 4.0) 1.0 (0.7, 1.0) < 0.001
BSFS score 5.5 (5.0, 6.0) 4.0 (4.0, 4.0) < 0.001
IBS-SSS 180.0 (150.0, 240.0) NA NA
Abdominal pain severity 40.0 (20.0, 50.0) NA NA
Abdominal pain frequency 30.0 (20.0, 40.0) NA NA
Abdominal bloating 10.0 (0.0, 20.0) NA NA
Bowel habit dissatisfaction 60.0 (60.0, 70.0) NA NA
Overall interference with QOL 30.0 (30.0, 50.0) NA NA
HADS anxiety score 5.0 (3.0, 10.0) 2.0 (0.0, 3.8) < 0.001
HADS depression score 4.0 (1.0, 7.0) 1.5 (0.0, 3.8) 0.009
VSI score 30.0 (19.0, 42.0) 4.0 (0.0, 13.3) < 0.001

The data are presented as the mean ± SD or the median (Q1, Q3). BSFS: Bristol stool form scale; HADS: Hospital anxiety and depression scale; IBS-D: Irritable bowel syndrome with predominant diarrhea; IBS-SSS: Irritable bowel syndrome symptom severity scale; NA: Not applicable; QOL: Quality of life; VSI: Visceral sensitivity index.